Bock, Clayton — Insider Profile

Insider Profile

Bock, Clayton

🔒 Follow — get an alert on any new filing

$STN

Companies Filed At

Open-Market Buys (2yr)

$440K

Buy Value (2yr, open-market)

Jun 26, 2026

Most Recent Trade

Credibility
Score

75%

Hit Rate

+0.3%

Avg 90d Return

+3.6%

Median 90d Return

Evaluated Trades

+5.5%

Best Trade

-11.5%

Worst Trade

Hit rate and returns are based on 4 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.

Cross-Company Track Record

33%

Hit Rate · 90d

-18.7%

Median Alpha · 90d

Closed Buys Evaluated

Beat XIU

All-insider base rate: 59% hit rate · +1.3% mean alpha (n=11504)

size concentrated

Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.

Research 3 closed buys with individual return outcomes available on the Research plan.

Date	Company	Role	Nature	Dir.	Shares	Price	Value	Score
Jun 26, 2026	$STN Stantec	—	Open Market	Buy	1,485	$69.15	$103K	63
May 19, 2026	$STN Stantec	—	Comp. Grant	Buy	1,540	—	—	63
Mar 16, 2026	$STN Stantec	—	Open Market	Buy	1,250	$88.92	$111K	63
Dec 31, 2025	$STN Stantec	—	Plan / DRIP	Buy	28	$133.13	$4K	63
Dec 31, 2025	$STN Stantec	—	Plan / DRIP	Buy	9	$134.86	$1K	63
Dec 31, 2025	$STN Stantec	—	Plan / DRIP	Buy	181	$93.41	$17K	63
Aug 25, 2025	$STN Stantec	—	Open Market	Buy	910	$110.45	$101K	63
Jun 20, 2025	$STN Stantec	—	Other	Sell	1,580	$143.72	$227K	63
Jun 20, 2025	$STN Stantec	—	Other	Sell	395	$133.69	$53K	63
May 22, 2025	$STN Stantec	—	Open Market	Buy	1,250	$100.37	$125K	63
May 20, 2025	$STN Stantec	—	Comp. Grant	Buy	516	$136.29	$70K	63
May 20, 2025	$STN Stantec	—	Comp. Grant	Buy	1,203	—	—	63
Jan 01, 2025	$STN Stantec	—	Other	Sell	—	—	—	63
Jan 01, 2025	$STN Stantec	—	Other	Sell	—	—	—	63
Jan 01, 2025	$STN Stantec	—	Other	Sell	—	—	—	63
Jan 01, 2025	$STN Stantec	—	Other	Sell	—	—	—	63

Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.